Tumor News and Research

RSS

Serum carcinoembryonic antigen level can reflect adrenal adenoma

The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance.

21 Nov 2007

How can we know early who will benefit from tumor target therapy?

The precise tailoring of tumor target treatment for patients with cancer is an unmet challenge.

21 Nov 2007

Whole-body positron emission tomography can reassure cervical cancer patients

Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.

21 Nov 2007

FDA clears Veridex test for the monitoring of metastatic colorectal cancer

Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.

21 Nov 2007

The science of cancer health disparities in racial/ethnic minorities and the medically underserved

The latest biological, clinical and social research behind how cancer affects different racial and ethnic groups will be the focus of the first American Association for Cancer Research conference on the topic, entitled "The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved."

21 Nov 2007

Bortezomib pushes cancer cells into overdrive, so that they self-destruct

University of Michigan Comprehensive Cancer Center researchers have discovered that bortezomib, a promising cancer drug, is able to strike a blow against melanoma tumor cells by revving up the action of a cancer-promoting gene.

21 Nov 2007

Dyslexia expert Dr. Bruce McCandliss awarded Presidential honor

Dr. Bruce McCandliss, a psychologist at the Sackler Institute for Developmental Psychobiology and associate professor of psychology in psychiatry at Weill Cornell Medical College, has received a commendation by the President of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE).

20 Nov 2007

Hormone norepinephrine may hasten the progression of certain blood cancers

Researchers here have shown that in cell cultures, the stress hormone norepinephrine appears to promote the biochemical signals that stimulate certain tumor cells to grow and spread.

20 Nov 2007

New guideline for how to treat a person's first unprovoked seizure

A guideline developed by the American Academy of Neurology recommends a routine electroencephalogram (EEG) and brain scans be considered when diagnosing and treating adults who experience their first unprovoked seizure.

19 Nov 2007

New device delivers radiation therapy to specific tumor sites

Physicians at the Rebecca and John Moores UCSD Cancer Center will present the initial outcomes of their use of a new device that delivers radiation therapy to a specific tumor site at the annual meeting of the Radiological Society of North America (RSNA), November 25-30, 2007, in Chicago, Illinois.

19 Nov 2007

Cannabis compound may stop the spread of breast cancer cells

A compound found in cannabis may prove to be effective at helping stop the spread of breast cancer cells throughout the body.

19 Nov 2007

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

Opening the doors to one of the first academic medical program dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery.

19 Nov 2007

The immune system can stop the growth of a cancerous tumor without actually killing it

A multinational team of researchers has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it.

19 Nov 2007

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.

19 Nov 2007

Block buster cancer drug Avastin gives hope to brain tumor victims

According to a new study the blockbuster cancer drug Avastin has shown promising results in treating brain cancer victims.

19 Nov 2007

Pre-malignant mammary lesions in dogs and humans display many of the same characteristics

...a discovery that could lead to better understanding of breast cancer progression and prevention for people and pets, said a Purdue University scientist from the School of Veterinary Medicine.

16 Nov 2007

How inhibitor-of-apoptosis chemicals kill tumors

Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy.

16 Nov 2007

CD200 stifles anti-tumor immunity

The prognosis for individuals with metastatic melanoma (MM) is not good. Therapeutic strategies to enhance the immune response have some clinical benefit; however, most patients eventually succumb to progressive disease, in part because their immune cells known as dendritic cells (DCs) fail to sustain an effective antitumor T cell immune response.

16 Nov 2007

Hormone orexin links sleep, hunger and metabolism

While investigating how the hormone orexin might control sleep and hunger, researchers at UT Southwestern Medical Center have discovered, to their surprise, that it activates a protein, HIF-1, long known to stimulate cancerous tumor growth.

15 Nov 2007

Histochemistry is the golden standard in the diagnosis of carcinosarcomas

The patient in the study was the first case of gastric carcinosarcoma obtained in this part of the world . The patient was admitted by Dr. Tomislav Randjelovic as surgeon and Dr. Branka Filipovic as gastroenterologist.

15 Nov 2007